Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
Air pollution and allergy.
J Investig Allergol Clin Immunol. 2000 Jan-Feb;10(1):5-10. Unique Identifier : AIDSLINE MED/20241704 Takafuji S; Nakagawa T; Department of Internal Medicine, St. Marianna University School; of Medicine, Kawasaki-city, Kanagawa, Japan.
Abstract:
Epidemiological studies have found a recent increase in the prevalence of allergic diseases, especially in industrialized countries. A change in environmental factors may be considered as one of the causes of this increase. It has been reported that the prevalence of allergic diseases is higher in polluted areas than in unpolluted ones. Therefore, we focused on the effect of one air pollutant, suspended particulate matter (SPM), on allergic responses. We showed that SPM had an enhancing effect on the IgE antibody production in mice. In Japan, the number of cars with diesel engines has increased rapidly, and it has been calculated that 35-80% of SPM in large cities consists of diesel exhaust particulates (DEP). We demonstrated that DEP had an adjuvant effect on the IgE antibody production in mice when administered intraperitoneally or intranasally. In humans, it has been shown that nasal challenge with DEP enhanced total IgE and specific IgE production in nasal lavages. Furthermore, it has been demonstrated that DEP had an enhancing effect on Th2-type cytokine synthesis in both mice and humans. It cannot be excluded that DEP may be related to the increase in prevalence of allergic diseases through the effect on the IgE antibody production and Th2-cytokine synthesis.
Keywords: JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL Air Pollutants/ADVERSE EFFECTS/*IMMUNOLOGY Air Pollution/*ADVERSE EFFECTS Animal Cytokines/BIOSYNTHESIS Gasoline/ADVERSE EFFECTS Human Hypersensitivity/EPIDEMIOLOGY/ETIOLOGY/*IMMUNOLOGY IgE/BIOSYNTHESIS Japan/EPIDEMIOLOGY Mice Th2 Cells/IMMUNOLOGY Vehicle Emissions/ADVERSE EFFECTS
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from
Elton John AIDS Foundation,
the National Library of Medicine,
and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.